Altria and Philip
Morris have been in talks since August about merging their operations after
separating roughly a decade ago. Altria
is a Dividend Champion having raised its dividend payments for nearly a half
century – 49 years. MO is also a holding
on the Dividend Farm first having been acquired decades years ago and held for the
duration.
Given the recent news
about MO, its Champion status, and the nature of its business, I decided it was
time to build a Scorecard for the firm.
Below is the card for Altria
as of September 13, 2019. The table
provides a snapshot of factors being scored. I’ll be assessing how
well MO meets my targets as well as whether or not it provides a better
investment fit than alternatives.
FACTOR
|
TARGET METRICS
|
LOW
|
CCC List
|
Champion
|
Champion
|
Current Yield
|
4.0%
|
7.34%
|
Company Profile
|
Red Flags?
|
Tobacco, vaping, cannabis, and liquor
|
Industry Leadership
|
Top 10
|
#1 by U.S. market share
|
Market Cap
|
$10 B+
|
$78.8 B
|
P/E
|
< 20
|
12.6
|
P/B
|
< 2
|
5.45
|
Debt / Equity
|
< 1
|
2.8
|
Dividend History (Years)
|
25
|
49
|
12 Month Price Range
|
Lower Half
|
Near 52-week low
|
Dividend Payout Ratio
|
< 75%
|
95.5%
|
Portfolio Weight
|
Under to Slightly Over
|
Slightly Over
|
CCC List: The DRIPinvesting.org web site provides the list of Champions, Contenders, and
Challengers where I normally start. Altria
is a Dividend Champion with nearly 50 years of dividend growth. It’s a strong record, well above my 25 year target.
Current Yield: MO’s trailing yield is 7.34% which is well above my
desired target by nearly double. The
long-term trend of dividend growth is a high double digit figure and the
payments are nice to get. However, a
yield eclipsing 7% can indicate a level of risk that isn’t warranted if the portfolio
weight is significant.
Company Profile: MO has been a cash cow for years. It has weathered major regulatory,
legislative, and public relations storms while continuing to generate a nice
dividend. One may wonder how long that
trend can continue as society here and abroad become increasingly health
conscious. MO has been working on
non-tobacco diversification, but it’s done so in other areas that may be as
risky, if not more so, than tobacco.
Industry
Leadership: MO is the #1 tobacco
firm in the U.S. by market share per Motley Fool.
Market Capitalization: Having a market cap exceeding $78 B means the firm
is nearly 8 times my minimum target.
This is great for investment stability even when the price is near its
52-week low.
Price to Earnings: The trailing P/E is nearly 40% below my high water
mark of 20. I appreciate ratios below
20. The price can bump up quite a ways
and still be within the bounds, so that’s good.
Price to Book: The P/B ratio is nearly 2.5x my comfort level. I don’t mind paying a small premium, but
premiums may come with risk. The bigger
the premium the larger the risk it seems.
Debt to Equity: Debt to equity is nearly 3x my max. MO has put a lot of money into new ventures
with limited cash flow history e.g., Cronos, making a Farmer wonder if the juice
(return) is worth the squeeze (debt).
Dividend History: Growing dividends for 49 years is great. Nearly doubling the minimum Champion range of
25 years speaks volumes about a firm’s consistent ability to throw off
cash. Furthermore, MO has accelerated
its dividend growth rate for the past 10 years.
As with nearly all things, acceleration is not infinite. Growth is an issue to watch.
Price Range: The price is within pennies of its trailing 12-month
(TTM) low as of this writing. That could
very well be bargain territory, even for those who are risk averse. However, the value has fallen by nearly
one-third during the past year. A
decline like that could be a real bonus to buyers or the harbinger of something
bad. Time will tell.
Payout Ratio: The payout ratio of 95.5% is beyond my 75% target
ceiling. MO has generated solid earnings
with which to support this ratio and done so for a long time. It stands to reason it will continue doing so
over the short run.
Portfolio Distribution: MO is a long-time holding for me. It predates my start as a Dividend Farmer –
by decades. The compound
growth associated with reinvested MO dividends has
helped bulk up the Dividend Farm, but adding additional weight may not be
prudent.
Analysis
My overall experience
with MO has been good – financially. The
dividend history and yield have treated me well as I’ve accumulated a solid position. The price currently appears favorable, but
the price to book, even at a depressed value, is bothersome. The same is true of the heavy debt incurred
by purchasing risky operations. The
public relations and regulatory volatility and uncertainty inherent in the
tobacco industry implies a level of risk I may not want if MO were a new add to
the farm. As a current crop, though, I
don’t believe I’ll discontinue farming it.
Instead, I’ll look at redirecting MO dividends to other financial crops
reducing MO’s weight in the portfolio without incurring selling costs or
capital gains taxes through aggressive rebalancing.
The thoughts expressed here
are those of the author, who is not a financial professional. Opinions
should not be considered investment advice. They are presented for
discussion and entertainment purposes only. For specific investment
advice or assistance, please contact a registered investment advisor, licensed
broker, or other financial professional.
No comments:
Post a Comment